Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Modafinil × Clear all

Phase

Status

Completed 18 Terminated 7 Unknown 3 Withdrawn 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Fatigue 1 Cognitive Dysfunction 1

Interventions

pembrolizumab 571 Specimen Handling 482 Carboplatin 454 Magnetic Resonance Spectroscopy 434 Cisplatin 409 Cyclophosphamide 404 Radiotherapy 357 Gemcitabine 315 Bevacizumab 313 Paclitaxel 300 Drug Therapy 285 Biopsy 285 Blood Specimen Collection 252 Nivolumab 238 Capecitabine 231 venetoclax 230 Oxaliplatin 229 fludarabine 224 Injections 211 Docetaxel 208 Fluorouracil 199 Dexamethasone 188 Radiosurgery 176 Rituximab 161 Pemetrexed 161 Standard of Care 158 atezolizumab 149 Surgical Procedures, Operative 148 durvalumab 146 Doxorubicin 138

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05333250 2026-01-13

MODIFY

Ottawa Hospital Research Institute

Phase 1/2 Recruiting

Fatigue, Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡